Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,610 · see citing works

<i>DPC4</i> , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · see citing works

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,100 · see citing works

A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy

Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270 · see citing works

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works

Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · see citing works

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works

DPC4 gene in various tumor types.

Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672 · see citing works

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

Smit, V. T. H. B. M., Boot, A. J., de Vries-Smits, A. M. M., Fleuren, G. J., Cornelisse, C. J., & Bos, J. L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.16.7773 · Cited by 625 · see citing works

Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas

Lieber, M. M., Mazzetta, J., Nelson‐Rees, W. A., Kaplan, M. J., & Todaro, G. J. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150505 · Cited by 509 · see citing works

Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase

Yunis, A. A., Arimura, G. K., & Russin, D. J. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190118 · Cited by 373 · see citing works

Pancreatic adenocarcinomas frequently show p53 gene mutations.

Scarpa, A., Capelli, P., Mukai, K., Zamboni, G., Oda, T., Iacono, C., & Hirohashi, S. (1993) · PubMed Central · Cited by 332 · see citing works

Allelotype of pancreatic adenocarcinoma using xenograft enrichment.

Hahn, S. A., Ab, S., Hoque, A. T., Schutte, M. E. M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., & Yeo, C. J. (1995) · PubMed · Cited by 310 · see citing works

Ki-ras oncogene activation in preinvasive pancreatic cancer

Lemoine, N. R., Jain, S., Hughes, C. M., Staddon, S. L., Maillet, B., Hall, P. A., & Klöppel, G. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91805-e · Cited by 247 · see citing works

Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L., Bossen, E. H., & Borowitz, M. J. (1982) · PubMed · Cited by 246 · see citing works

A cystic fibrosis pancreatic adenocarcinoma cell line.

Schoumacher, R., Ram, J., Iannuzzi, M. C., Bradbury, N. A., Wallace, R. W., Hon, C. T., Kelly, D. R., Schmid, S. M., Gelder, F. B., & Rado, T. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.4012 · Cited by 243 · see citing works

Allelotype of pancreatic adenocarcinoma.

Seymour, A. B., Hruban, R. H., Redston, M. S., Caldas, C., Powell, S. M., Kinzler, K. W., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 203 · see citing works

p53 and K-RAS alterations in pancreatic epithelial cell lesions.

Kalthoff, H., Schmiegel, W., Röder, C., Kasche, D., Schmidt, A., Lauer, G., Thiele, H. G., Honold, G., Pantel, K., & Riethmüller, G. (1993) · PubMed · Cited by 185 · see citing works

Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.

Ruggeri, B., Zhang, S.-Y., Caamaño, J., DiRado, M., Flynn, S. D., & Klein–Szanto, A. J. (1992) · PubMed · Cited by 172 · see citing works

Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites

Chen, W. H., Horoszewicz, J. S., Leong, S. S., Shimano, T., Penetrante, R. B., Sanders, W. H., Berjian, R. A., Douglass, H. O., Martin, E. W., & Chu, T. M. (1982) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02796382 · Cited by 163 · see citing works

DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.

Kim, S. K., Fan, Y.-H., Papadimitrakopoulou, V. A., Clayman, G. L., Hittelman, W. N., Hong, W. K., Lotan, R., & Mao, L. (1996) · PubMed · Cited by 159 · see citing works

Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9.

Iwamura, T., Katsuki, T., & Ide, K. (1987) · PubMed · Cited by 152 · see citing works

Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.

Hahn, S. A., Bartsch, D. K., Schroers, A., Galehdari, H., Becker, M. A., Ramaswamy, A., Schwarte‐Waldhoff, I., Maschek, H., & Schmiegel, W. (1998) · PubMed · Cited by 146 · see citing works

Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas

MacGrogan, D., Pegram, M. D., Slamon, D. J., & Bookstein, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201232 · Cited by 125 · see citing works

CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas

Holland, E. A., Schmid, H., Kefford, R. F., & Mann, G. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4 · Cited by 112 · see citing works

Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.

Barrett, M. T., Schutte, M. E. M., Kern, S. E., & Reid, B. J. (1996) · PubMed · Cited by 89 · see citing works

Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice

Grant, A. G., Duke, D., & Hermon-Taylor, J. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.24 · Cited by 67 · see citing works

Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms.

Lei, J.-Y., Zou, T., Shi, Y. Q., Zhou, X., Smolinski, K. N., Yin, J., Souza, R. F., Appel, R., Wang, S., Cymes, K., et al. (1996) · PubMed · Cited by 66 · see citing works

Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice.

Dexter, D. L., Matook, G. M., Meitner, P. A., Bogaars, H. A., Jolly, G., Turner, M. D., & Calabresi, P. (1982) · PubMed · Cited by 59 · see citing works

DPC4 gene mutation in colitis associated neoplasia.

Hoque, A. T. M. S., Hahn, S. A., Schutte, M. E. M., & Kern, S. E. (1997) · Gut · doi:10.1136/gut.40.1.120 · Cited by 53 · see citing works

Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.

Kong, X., Choi, S. H., Inoue, A., Xu, F., Chen, T.-X., Takita, J., Yokota, J., Bessho, F., Yanagisawa, M., Hanada, R., et al. (1997) · PubMed · Cited by 47 · see citing works

Absence or low number of telomere repeats at junctions of dicentric chromosomes

Wan, T. S. K., Martens, U. M., Poon, S. S. S., Tsao, S., Ha, S., & Lansdorp, P. M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1 · Cited by 45 · see citing works

Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc-3

Frazier, M. L., Pathak, S., Wang, Z., Cleary, K. R., Singletary, S. E., Olivé, M., Mackay, B., Steck, P. A., & Levin, B. (1990) · Pancreas · doi:10.1097/00006676-199001000-00002 · Cited by 44 · see citing works

Successful xenografting of cryopreserved primary pancreatic cancers

Sorio, C., Bonora, A., Orlandini, S., Moore, P. S., Capelli, P., Cristofori, P. G., Negro, G. D., Marchiori, P. N., Gaviraghi, G., Falconi, M., et al. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000343 · Cited by 35 · see citing works

Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas

Bartsch, D. K., Barth, P. J., Bastian, D., Ramaswamy, A., Gerdes, B., Chaloupka, B., Deiss, Y., Simon, B., & Schudy, A. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00380-2 · Cited by 27 · see citing works

Rare Alteration of Genomic Structure or Expression of the DPC4 Gene in Myelogenous Leukemias

Kaneko, H., Horiike, S., Sasai, Y., Iwai, T., Nakao, M., Yokota, S., Taniwaki, M., Kashima, K., & Misawa, S. (1998) · Acta Haematologica · doi:10.1159/000040837 · Cited by 7 · see citing works

Untitled work

(2000) · doi:10.1002/(sici)1098-2264(200004)27:4

Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer*

Kahlert, C., Melo, S., Protopopov, A., Tang, J., Seth, S., Koch, M., Zhang, J.-H., Weitz, J., Chin, L., Futreal, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.532267 · Cited by 896 · see citing works

Phenotype and Genotype of Pancreatic Cancer Cell Lines

Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936 · see citing works

Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth

Kashatus, J. A., Nascimento, A., Myers, L. J., Sher, A., Byrne, F. L., Hoehn, K. L., Counter, C. M., & Kashatus, D. F. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.002 · Cited by 700 · see citing works

Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling

Zimmermann, G., Papke, B., Ismail, S., Vartak, N., Chandra, A., Hoffmann, M., Hahn, S. A., Triola, G., Wittinghofer, A., Bastiaens, P. I. H., et al. (2013) · Nature · doi:10.1038/nature12205 · Cited by 596 · see citing works

p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509 · see citing works

Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

Arlt, A., Gehrz, A., Müerköster, S. S., Vorndamm, J., Kruse, M., Fölsch, U. R., & Schäfer, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206390 · Cited by 474 · see citing works

Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer

Zhao, R., Choi, B. Y., Lee, M.-H., Bode, A. M., & Dong, Z. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.017 · Cited by 425 · see citing works

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis

Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes &amp; Development · doi:10.1101/gad.1549407 · Cited by 422 · see citing works

3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing

Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-95 · Cited by 394 · see citing works

NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · see citing works

Activation of RalA is critical for Ras-induced tumorigenesis of human cells

Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355 · see citing works

Frequency of K-ras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Meta-Analysis

Löhr, M., Klöppel, G., Maisonneuve, P., Lowenfels, A. B., & Lüttges, J. (2005) · Neoplasia · doi:10.1593/neo.04445 · Cited by 343 · see citing works

SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models

Fedele, C., Ran, H., Diskin, B., Wei, W., Jen, J., Geer, M. J., Araki, K., Ozerdem, U., Simeone, D. M., Miller, G., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0444 · Cited by 315 · see citing works

Tumour maintenance is mediated by eNOS

Lim, K., Ancrile, B. B., Kashatus, D. F., & Counter, C. M. (2008) · Nature · doi:10.1038/nature06778 · Cited by 315 · see citing works

A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

Sipos, B., Möser, S., Kalthoff, H., Török, V., Löhr, M. J., & Klöppel, G. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0784-4 · Cited by 309 · see citing works

Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases With and 152 Cases Without Pancreatic Ductal Adenocarcinoma

Andea, A. A., Sarkar, F. H., & Adsay, V. N. (2003) · Modern Pathology · doi:10.1097/01.mp.0000087422.24733.62 · Cited by 290 · see citing works

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples

Simbolo, M., Gottardi, M., Corbo, V., Fassan, M., Mafficini, A., Malpeli, G., Lawlor, R. T., & Scarpa, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062692 · Cited by 283 · see citing works

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy

Lister, A., Nedjadi, T., Kitteringham, N. R., Campbell, F., Costello, E., Lloyd, B. H., Copple, I. M., Williams, S. J., Owen, A., Neoptolemos, J. P., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-37 · Cited by 243 · see citing works

Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer

Harikumar, K. B., Kunnumakkara, A. B., Sethi, G., Diagaradjane, P., Anand, P., Pandey, M. K., Gelovani, J. G., Krishnan, S., Guha, S., & Aggarwal, B. B. (2010) · International Journal of Cancer · doi:10.1002/ijc.25041 · Cited by 232 · see citing works

Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Pozza, E. D., Scupoli, M. T., Scarpa, A., Zappavigna, S., Marra, M., Abbruzzese, A., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.36 · Cited by 228 · see citing works

NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells

Maier, H. J., Schmidt-Straßburger, U., Huber, M. A., Wiedemann, E. M., Beug, H., & Wirth, T. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.003 · Cited by 215 · see citing works

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

Wang, J.-G., Geddings, J. E., Aleman, M. M., Cardenas, J. C., Chantrathammachart, P., Williams, J., Kirchhofer, D., Bogdanov, V. Y., Bach, R. R., Rak, J. W., et al. (2012) · Blood · doi:10.1182/blood-2012-01-402156 · Cited by 203 · see citing works

Blockage of Intermediate-Conductance Ca2+-Activated K+ Channels Inhibit Human Pancreatic Cancer Cell Growth in Vitro

Jäger, H., Dreker, T., Buck, A., Giehl, K., Gress, T. M., & Grissmer, S. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.630 · Cited by 196 · see citing works

Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress‐independent growth inhibition of pancreatic cancer cells through G2/M cell‐cycle arrest and apoptosis

Li, W., Xie, L., Chen, Z., Zhu, Y., Sun, Y., Miao, Y., Xu, Z., & Han, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01523.x · Cited by 185 · see citing works

Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

Arlt, A., Vorndamm, J., Müerköster, S. S., Yu, H., Schmidt, W. E., Fölsch, U. R., & Schäfer, H. (2002) · PubMed · Cited by 173 · see citing works

Orthotopic Transplantation Models of Pancreatic Adenocarcinoma Derived From Cell Lines and Primary Tumors and Displaying Varying Metastatic Activity

Loukopoulos, P., Kanetaka, K., Takamura, M., Shibata, T., Sakamoto, M., & Hirohashi, S. (2004) · Pancreas · doi:10.1097/00006676-200410000-00004 · Cited by 172 · see citing works

Triptolide Induces Cell Death in Pancreatic Cancer Cells by Apoptotic and Autophagic Pathways

Mujumdar, N. R., MacKenzie, T. N., Dudeja, V., Chugh, R., Antonoff, M. B., Borja–Cacho, D., Sangwan, V., Dawra, R. K., Vickers, S. M., & Saluja, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.046 · Cited by 171 · see citing works

Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

Lopes, R., Gangeswaran, R., McNeish, I. A., Wang, Y., & Lemoine, N. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22554 · Cited by 156 · see citing works

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine

Donadelli, M., Costanzo, C., Beghelli, S., Scupoli, M. T., Dandrea, M., Bonora, A., Piacentini, P., Budillon, A., Caraglia, M., Scarpa, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.002 · Cited by 157 · see citing works

Apoptosis: targets in pancreatic cancer.

Westphal, S., & Kalthoff, H. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-6 · Cited by 148 · see citing works

Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth

Nagdas, S., Kashatus, J. A., Nascimento, A., Hussain, S. S., Trainor, R. E., Pollock, S. R., Adair, S. J., Michaels, A. D., Sesaki, H., Stelow, E. B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.031 · Cited by 145 · see citing works

Pharmacologic Inhibition of RAF→MEK→ERK Signaling Elicits Pancreatic Cancer Cell Cycle Arrest Through Induced Expression of p27Kip1

Gysin, S., Lee, S., Dean, N. M., & McMahon, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2848 · Cited by 147 · see citing works

Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo

Vogler, M., Walczak, H., Stadel, D., Haas, T. L., Genze, F., Jovanovic, M., Gschwend, J. E., Simmet, T., Debatin, K., & Fulda, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1296 · Cited by 148 · see citing works

Molecular Signatures of Pancreatic Cancer

Hong, S., Park, J. Y., Hruban, R. H., & Goggins, M. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0566-ra.1 · Cited by 146 · see citing works

Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest

Nicolás, F. J., & Hill, C. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206420 · Cited by 141 · see citing works

Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers

Mauri, P., Scarpa, A., Nascimbeni, A. C., Benazzi, L., Parmagnani, E., Mafficini, A., Peruta, M. D., Bassi, C., Miyazaki, K., & Sorio, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3000fje · Cited by 137 · see citing works

Surgical and molecular pathology of pancreatic neoplasms

Hackeng, W. M., Hruban, R. H., Offerhaus, G. J. A., & Brosens, L. A. A. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0497-z · Cited by 130 · see citing works

Intraductal and Papillary Variants of Acinar Cell Carcinomas

Baştürk, O., Zamboni, G., Klimstra, D. S., Capelli, P., Andea, A. A., Kamel, N. S., & Adsay, V. N. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213376.09795.9f · Cited by 127 · see citing works

Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti‐inflammatory activities in pancreatic tumor cells

Kürbitz, C., Heise, D., Redmer, T., Goumas, F. A., Arlt, A., Lemke, J., Rimbach, G. H., Kalthoff, H., & Trauzold, A. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01870.x · Cited by 124 · see citing works

Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells

Rahn, S., Zimmermann, V., Viol, F., Knaack, H., Stemmer, K., Peters, L., Lenk, L., Ungefroren, H., Saur, D., Schäfer, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.004 · Cited by 124 · see citing works

Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness

Gaspar, N. J., Li, L., Kapoun, A. M., Medicherla, S., Reddy, M., Li, G., O’Young, G., Quon, D. H., Henson, M., Damm, D. L., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029025 · Cited by 120 · see citing works

Prognostic and predictive markers in pancreatic adenocarcinoma

Le, N. N. H., Sund, M., Vinci, A., Beyer, G., Javed, M., Krug, S., Neessee, A., & Schober, M. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.001 · Cited by 120 · see citing works

Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer

Desir, S., O’Hare, P., Vogel, R. I., Sperduto, W., Sarkari, A., Dickson, E. L., Wong, P., Nelson, A., Fong, Y., Steer, C. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27649-x · Cited by 120 · see citing works

Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery

Li, J., Wientjes, M. G., & Au, J. L. ‐. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9181-5 · Cited by 120 · see citing works

Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer

Ashrafizadeh, M., Bakhoda, M. R., Bahmanpour, Z., Ilkhani, K., Zarrabi, A., Makvandi, P., Khan, H. Z., Mazaheri, S., Darvish, M., & Mirzaei, H. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00829 · Cited by 114 · see citing works

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer

Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040177 · Cited by 110 · see citing works

Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways

Brandi, J., Dando, I., Pozza, E. D., Biondani, G., Jenkins, R. E., Elliott, V., Park, K., Fanelli, G., Zolla, L., Costello, E., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.10.002 · Cited by 106 · see citing works

Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer

Edling, C. E., Selvaggi, F., Buus, R., Maffucci, T., Sebastiano, P. D., Friess, H., Innocenti, P., Kocher, H. M., & Falasca, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1210 · Cited by 102 · see citing works

Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells

Donadelli, M., Costanzo, C., Faggioli, L., Scupoli, M. T., Moore, P. S., Bassi, C., Scarpa, A., & Palmieri, M. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10145 · Cited by 101 · see citing works

Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations

Azmi, A. S., Wang, Z., Philip, P. A., Mohammad, R. M., & Sarkar, F. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0642 · Cited by 100 · see citing works

SMAD4 and its role in pancreatic cancer

Xia, X., Wu, W., Huang, C., Cen, G., Jiang, T., Cao, J., Huang, K., & Qiu, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2883-z · Cited by 97 · see citing works

Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects

Neureiter, D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7830 · Cited by 98 · see citing works

K-ras Mutation and p16 and Preproenkephalin Promoter Hypermethylation in Plasma DNA of Pancreatic Cancer Patients

Jiao, L., Zhu, J., Hassan, M. M., Evans, D. B., Abbruzzese, J. L., & Li, D. (2006) · Pancreas · doi:10.1097/01.mpa.0000246665.68869.d4 · Cited by 96 · see citing works

Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo

Brockschmidt, C., Hirner, H., Huber, N., Eismann, T., Hillenbrand, A., Giamas, G., Radunsky, B., Ammerpohl, O., Böhm, B. O., Henne‐Bruns, D., et al. (2008) · Gut · doi:10.1136/gut.2007.123695 · Cited by 96 · see citing works

Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer

Geismann, C., Morscheck, M., Koch, D., Bergmann, F., Ungefroren, H., Arlt, A., Tsao, M., Bachem, M. G., Altevogt, P., Sipos, B., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3493 · Cited by 95 · see citing works

Intraductal neoplasms of the pancreas

Klöppel, G., Baştürk, O., Schlitter, A. M., Konukiewitz, B., & Esposito, I. (2014) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2014.08.005 · Cited by 94 · see citing works

Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic Cancer

Roda, O., Zapater, E. O., Martínez‐Bosch, N., Gallego, R. G., Vila‐Perelló, M., Ampurdanés, C., Gabius, H., André, S., Andreu, D., Real, F. X., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.039 · Cited by 94 · see citing works

Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-β Switch from a Suppressor to a Promoter of Cancer Cell Proliferation

Singh, G., Singh, S. K., König, A. O., Reutlinger, K., Nye, M. D., Adhikary, T., Eilers, M., Gress, T. M., Fernández-Zapico, M. E., & Ellenrieder, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100438 · Cited by 92 · see citing works

Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells

Montani, M. S. G., Granato, M., Santoni, C., Porto, P. D., Merendino, N., D’Orazi, G., Faggioni, A., & Cirone, M. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0314-z · Cited by 92 · see citing works

ATP-Binding Cassette C Transporters in Human Pancreatic Carcinoma Cell Lines

Hagmann, W., Jesnowski, R., Faissner, R., Guo, C., & Löhr, M. J. (2008) · Pancreatology · doi:10.1159/000178884 · Cited by 90 · see citing works

p53-Independent Endoplasmic Reticulum Stress-Mediated Cytotoxicity of a Newcastle Disease Virus Strain in Tumor Cell Lines

Fábián, Z., Csatary, C. M., Szeberényi, J., & Csatáry, L. K. (2007) · Journal of Virology · doi:10.1128/jvi.02490-06 · Cited by 88 · see citing works

TGFβ Signaling in the Pancreatic Tumor Microenvironment

Principe, D. R., Timbers, K. E., Atia, L. G., Koch, R. M., & Rana, A. (2021) · Cancers · doi:10.3390/cancers13205086 · Cited by 86 · see citing works

KLF11 mediates a critical mechanism in TGF-β signaling that is inactivated by Erk-MAPK in pancreatic cancer cells

Ellenrieder, V., Buck, A., Harth, A. J., Jungert, K., Buchholz, M., Adler, G., Urrutia, R. A., & Gress, T. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.018 · Cited by 86 · see citing works

Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway

Missiaglia, E., Donadelli, M., Palmieri, M., Crnogorac‐Jurcevic, T., Scarpa, A., & Lemoine, N. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208018 · Cited by 83 · see citing works

Cyclin-Dependent Kinase 5 Is Amplified and Overexpressed in Pancreatic Cancer and Activated by Mutant K-Ras

Eggers, J. P., Grandgenett, P. M., Collisson, E. C., Lewallen, M. E., Tremayne, J. R., Singh, P. K., Swanson, B. J., Andersen, J. M., Caffrey, T. C., High, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2288 · Cited by 81 · see citing works

SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells

Verdon, Q., Boonen, M., Ribes, C., Jadot, M., Gasnier, B., & Sagné, C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617066114 · Cited by 80 · see citing works

Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells

Al‐Assar, O., Demiciorglu, F., Lunardi, S., Gaspar-Carvalho, M. M., McKenna, W. G., Muschel, R. J., & Brunner, T. B. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.03.014 · Cited by 79 · see citing works

Smad4/DPC4-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β in Pancreatic Tumor Cells

Chen, W., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., & Ungefroren, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203709200 · Cited by 79 · see citing works

Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation

Piacentini, P., Donadelli, M., Costanzo, C., Moore, P. S., Palmieri, M., & Scarpa, A. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0173-x · Cited by 78 · see citing works

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells

Cordani, M., Butera, G., Dando, I., Torrens‐Mas, M., Butturini, E., Pacchiana, R., Oppici, E., Cavallini, C., Gasperini, S., Tamassia, N., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0288-2 · Cited by 77 · see citing works

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells

Moore, P. S., Barbi, S., Donadelli, M., Costanzo, C., Bassi, C., Palmieri, M., & Scarpa, A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.07.001 · Cited by 77 · see citing works

Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer

Brancato, V., Comunanza, V., Imparato, G., Corà, D., Urciuolo, F., Noghero, A., Bussolino, F., & Netti, P. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.072 · Cited by 77 · see citing works

Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53

Li, J., Lama, R., Galster, S. L., Inigo, J. R., Wu, J., Chandra, D., Chemler, S. R., & Wang, X. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0728 · Cited by 80 · see citing works

Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells

Yoshino, Y., & Ishioka, C. (2015) · Scientific Reports · doi:10.1038/srep13249 · Cited by 73 · see citing works

Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway

Paron, I., Berchtold, S., Vörös, J., Shamarla, M., Erkan, M., Höfler, H., & Esposito, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021684 · Cited by 76 · see citing works

Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells

Gaviraghi, M., Tunici, P., Valensin, S., Rossi, M., Giordano, C., Magnoni, L., Dandrea, M., Montagna, L., Ritelli, R., Scarpa, A., et al. (2010) · Bioscience Reports · doi:10.1042/bsr20100018 · Cited by 76 · see citing works

Upregulated SMAD3 promotes epithelial–mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma

Yamazaki, K., Masugi, Y., Effendi, K., Tsujikawa, H., Hiraoka, N., Kitago, M., Shinoda, M., Itano, O., Tanabe, M., Kitagawa, Y., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.53 · Cited by 75 · see citing works

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling

Ischenko, I., Čamaj, P., Seeliger, H., Kleespies, A., Guba, M. O., Toni, E. N. D., Schwarz, B., Graeb, C., Eichhorn, M., Jauch, K. ‐., et al. (2008) · Oncogene · doi:10.1038/onc.2008.326 · Cited by 75 · see citing works

Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK ‐3β/ NF ‐κ B signaling cascade

Johnson, J. L., & de Mejı́a, E. G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300307 · Cited by 75 · see citing works

Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)–Deficient Pancreatic Cancer Cells

Wang, H., Han, H., & Hoff, D. D. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4602 · Cited by 73 · see citing works

Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells

Wang, Y., Zhang, Y., Yang, J., Ni, X., Liu, S., Li, Z., Hodges, S. E., Fisher, W. E., Brunicardi, F. C., Gibbs, R. A., et al. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218868 · Cited by 72 · see citing works

Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility

Yamazaki, K., Takamura, M., Masugi, Y., Mori, T., Du, W., Hibi, T., Hiraoka, N., Ohta, T., Ohki, M., Hirohashi, S., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.5 · Cited by 71 · see citing works

Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines

Gysin, S., Rickert, P., Kastury, K., & McMahon, M. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20216 · Cited by 70 · see citing works

Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells

Montani, M. S. G., Cecere, N., Granato, M., Romeo, M. A., Falcinelli, L., Ciciarelli, U., D’Orazi, G., Faggioni, A., & Cirone, M. (2019) · Cancers · doi:10.3390/cancers11050703 · Cited by 68 · see citing works

Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status

Mudali, S., Fu, B., Lakkur, S. S., Luo, M., Embuscado, E. E., & Iacobuzio–Donahue, C. A. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9045-7 · Cited by 67 · see citing works

Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status

Kimple, R. J., Vaseva, A. V., Cox, A. D., Baerman, K. M., Calvo, B. F., Tepper, J. E., Shields, J. M., & Sartor, C. I. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1324 · Cited by 66 · see citing works

Precise and efficient silencing of mutant KrasG12D by CRISPR-CasRx controls pancreatic cancer progression

Jiang, W., Li, H., Liu, X., Zhang, J., Zhang, W., Li, T., Liu, L., & Yu, X. (2020) · Theranostics · doi:10.7150/thno.46642 · Cited by 65 · see citing works

P53 Mutations Change Phosphatidylinositol Acyl Chain Composition

Naguib, A., Bencze, G., Engle, D. D., Chio, I. I. C., Herzka, T. M., Watrud, K. E., Bencze, S., Tuveson, D. A., Pappin, D., & Trotman, L. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.010 · Cited by 65 · see citing works

Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic Duct Dilation

Takano, S., Fukasawa, M., Maekawa, S., Kadokura, M., Miura, M., Shindo, H., Takahashi, E., Sato, T., & Enomoto, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098718 · Cited by 64 · see citing works

Cooperation of Musashi‐2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer

Sheng, W., Dong, M., Chen, C., Wang, Z., Li, Y., Wang, K., Li, Y., & Zhou, J. (2017) · The FASEB Journal · doi:10.1096/fj.201601240r · Cited by 64 · see citing works

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

Monti, P., Marchesi, F., Reni, M., Mercalli, A., Sordi, V., Zerbi, A., Balzano, G., Carlo, V. D., Allavena, P., & Piemonti, L. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1053-x · Cited by 64 · see citing works

Over‐expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis

Ohuchida, K., Mizumoto, K., Miyasaka, Y., Yu, J. Q., Cui, L., Yamaguchi, H., Toma, H., Takahata, S., Sato, N., Nagai, E., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2250 · Cited by 63 · see citing works

Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines

García-Morales, P., Gómez‐Martínez, Á., Carrato, A., Martínez-Lacaci, I., Barberá, V. M., Soto, J. L., Carrasco‐García, E., Menéndez-Gutierrez, M. P., Castro-Galache, M. D., Ferragut, J. A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0186 · Cited by 63 · see citing works

Docosahexaenoic Acid Induces Apoptosis in the Human PaCa-44 Pancreatic Cancer Cell Line by Active Reduced Glutathione Extrusion and Lipid Peroxidation

Merendino, N., Loppi, B., D'Aquino, M., Molinari, R., Pessina, G., Romano, C., & Velotti, F. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5202_12 · Cited by 61 · see citing works

MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines

Dandrea, M., Donadelli, M., Costanzo, C., Scarpa, A., & Palmieri, M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp723 · Cited by 61 · see citing works

Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers

Öberg, D., Yanover, E., Adam, V. S., Sweeney, K. G., Costas, C., Lemoine, N. R., & Halldén, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1960 · Cited by 61 · see citing works

Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas

Ohike, N., Maass, N., Mundhenke, C., Biallek, M., Zhang, M., Jonat, W., Lüttges, J., Morohoshi, T., Klöppel, G., & Nagasaki, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00390-2 · Cited by 61 · see citing works

Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis

Fiorini, C., Menegazzi, M., Padroni, C., Dando, I., Pozza, E. D., Gregorelli, A., Costanzo, C., Palmieri, M., & Donadelli, M. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0790-6 · Cited by 60 · see citing works

Ductal Neoplasia of the Pancreas: Nosologic, Clinicopathologic, and Biologic Aspects

Adsay, V. N., Baştürk, O., Cheng, J. D., & Andea, A. A. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.04.001 · Cited by 60 · see citing works

Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.

Sun, C., Yamato, T., Furukawa, T., Ohnishi, Y., Kijima, H., & Horii, A. (2001) · Oncology Reports · doi:10.3892/or.8.1.89 · Cited by 89 · see citing works

Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma

Simon, B., Weinel, R. J., Höhne, M. W., Watz, J., Schmidt, J., Körtner, G., & Arnold, R. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90422-7 · Cited by 75 · see citing works

Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient Survival

Shin, S. H., Kim, S. C., Hong, S.-M., Kim, Y. H., Song, K.-B., Park, K.-M., & Lee, Y.-J. (2013) · Pancreas · doi:10.1097/mpa.0b013e31825b6ab0 · Cited by 107 · see citing works

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works

Establishment and characterization of four human pancreatic carcinoma cell lines

Ku, J., Yoon, K., Kim, W. H., Jang, J., Suh, K., Kim, S., Park, Y.-H., & Park, J. (2002) · Cell and Tissue Research · doi:10.1007/s00441-001-0510-y · Cited by 20 · see citing works